Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.

Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Bolaños-Meade J, Panepinto JA, Rondelli D, Shenoy S, Williamson J, Woolford TL, Gluckman E, Wagner JE, Tisdale JF.

Lancet Haematol. 2019 Sep 5. pii: S2352-3026(19)30154-1. doi: 10.1016/S2352-3026(19)30154-1. [Epub ahead of print]

PMID:
31495699
2.

Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination.

Hoshitsuki K, Crews KR, Yang W, Smith CA, Hankins JS, Turner AJ, Broeckel U, McMillin GA, Relling MV, Haidar CE.

Genet Med. 2019 Jul 25. doi: 10.1038/s41436-019-0614-y. [Epub ahead of print] No abstract available.

PMID:
31341243
3.

Acute Chest Syndrome After Splenectomy in Children With Sickle Cell Disease.

El-Gohary Y, Fleming A, Zhang H, Estepp JH, Hankins JS, Wang W, Davidoff AM, Murphy AJ.

J Surg Res. 2019 Oct;242:336-341. doi: 10.1016/j.jss.2019.04.077. Epub 2019 May 23.

PMID:
31129243
4.

Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results.

Adesina OO, Gurney JG, Kang G, Villavicencio M, Hodges JR, Chemaitilly W, Kaste SC, Zemel BS, Hankins JS.

Blood Adv. 2019 May 14;3(9):1476-1488. doi: 10.1182/bloodadvances.2018026047.

5.

Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.

Yates AM, Joshi VM, Aygun B, Moen J, Smeltzer MP, Govindaswamy D, Dowdy J, Cotton A, Kang G, Ware RE, Hankins JS.

Pediatr Blood Cancer. 2019 Jul;66(7):e27717. doi: 10.1002/pbc.27717. Epub 2019 Mar 25.

PMID:
30907497
6.

Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life.

Zahr RS, Rampersaud E, Kang G, Weiss MJ, Wu G, Davis RL, Hankins JS, Estepp JH, Lebensburger J.

Haematologica. 2019 Sep;104(9):e385-e387. doi: 10.3324/haematol.2018.212779. Epub 2019 Mar 19. No abstract available.

7.

Autoregressive moving average modeling for hepatic iron quantification in the presence of fat.

Tipirneni-Sajja A, Krafft AJ, Loeffler RB, Song R, Bahrami A, Hankins JS, Hillenbrand CM.

J Magn Reson Imaging. 2019 Nov;50(5):1620-1632. doi: 10.1002/jmri.26682. Epub 2019 Feb 13.

PMID:
30761652
8.

Erratum to: Fast quantitative parameter maps without fitting: Integration yields accurate mono-exponential signal decay rates (Magn Reson Med 2018;79:2978-2985).

Song R, Loeffler RB, Holtrop JL, McCarville MB, Hankins JS, Hillenbrand CM.

Magn Reson Med. 2019 Feb;81(2):1470. doi: 10.1002/mrm.27405. Epub 2018 Oct 9. No abstract available.

PMID:
30536974
9.

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.

Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson A, Kalinyak K, DeBaun M, Treadwell M.

Hematology. 2019 Dec;24(1):189-198. doi: 10.1080/16078454.2018.1549801.

PMID:
30479187
10.

The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children.

Gammal RS, Caudle KE, Quinn CT, Wang WC, Gaedigk A, Prows CA, Haidar CE, Taylor AK, Klein TE, Sangkuhl K, Hankins JS, Crews KR.

Clin Pharmacol Ther. 2019 Jun;105(6):1300-1302. doi: 10.1002/cpt.1260. Epub 2018 Nov 22. No abstract available.

PMID:
30467830
11.

Ventricular global longitudinal strain is altered in children with sickle cell disease.

Whipple NS, Naik RJ, Kang G, Moen J, Govindaswamy SD, Fowler JA, Dowdy J, Penkert R, Joshi VM, Hankins JS.

Br J Haematol. 2018 Dec;183(5):796-806. doi: 10.1111/bjh.15607. Epub 2018 Nov 19.

PMID:
30450553
12.

Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.

Zahr RS, Hankins JS, Kang G, Li C, Wang WC, Lebensburger J, Estepp JH.

Am J Hematol. 2019 Jan;94(1):E27-E29. doi: 10.1002/ajh.25329. Epub 2018 Nov 29. No abstract available.

PMID:
30359463
13.

Ultrashort echo time imaging for quantification of hepatic iron overload: Comparison of acquisition and fitting methods via simulations, phantoms, and in vivo data.

Tipirneni-Sajja A, Loeffler RB, Krafft AJ, Sajewski AN, Ogg RJ, Hankins JS, Hillenbrand CM.

J Magn Reson Imaging. 2019 May;49(5):1475-1488. doi: 10.1002/jmri.26325. Epub 2018 Oct 25.

PMID:
30358001
14.

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies.

Robinson KM, Yang W, Haidar CE, Hankins JS, Jay DW, Kornegay N, Rubnitz JE, Broeckel U, Cheng C, Pui CH, Jeha S, Relling MV.

Pharmacogenomics J. 2019 Jun;19(3):305-314. doi: 10.1038/s41397-018-0043-3. Epub 2018 Sep 12.

15.

The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease.

DiMartino LD, Baumann AA, Hsu LL, Kanter J, Gordeuk VR, Glassberg J, Treadwell MJ, Melvin CL, Telfair J, Klesges LM, King A, Wun T, Shah N, Gibson RW, Hankins JS; Sickle Cell Disease Implementation Consortium.

Am J Hematol. 2018 Dec;93(12):E391-E395. doi: 10.1002/ajh.25282. Epub 2018 Oct 17. No abstract available.

16.

Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.

Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, Brandow AM, Lebensburger JD, Adesina O, Chou ST, Zemel BS, Smeltzer MP, Wang WC, Gurney JG.

Pediatr Blood Cancer. 2018 Sep;65(9):e27228. doi: 10.1002/pbc.27228. Epub 2018 May 24.

PMID:
29797644
17.

Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease.

Cronin RM, Hankins JS, Byrd J, Pernell BM, Kassim A, Adams-Graves P, Thompson AA, Kalinyak K, DeBaun MR, Treadwell M.

Hematology. 2018 Oct;23(9):683-691. doi: 10.1080/10245332.2018.1457200. Epub 2018 Mar 29.

PMID:
29595096
18.

A Retrospective Review to Determine If Children with Sickle Cell Disease Receive Hydroxyurea Monitoring.

Creary SE, O'Brien SH, Stanek J, Hankins JS, Garee A, Ball KR, Andrews TM, Chisolm DJ.

Pediatr Qual Saf. 2017 May-Jun;2(3). pii: e024. Epub 2017 May 25.

19.

Using Qualitative Perspectives of Adolescents with Sickle Cell Disease and Caregivers to Develop Healthcare Transition Programming.

Porter JS, Lopez AD, Wesley KM, Magdovitz-Frankfurt P, Anderson SM, Cole AR, Boggs J, Hankins JS.

Clin Pract Pediatr Psychol. 2017 Dec;5(4):319-329. doi: 10.1037/cpp0000212.

20.

Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia.

Penkert RR, Hurwitz JL, Thomas P, Rosch J, Dowdy J, Sun Y, Tang L, Hankins JS.

Haematologica. 2018 Feb;103(2):e50-e54. doi: 10.3324/haematol.2017.177360. Epub 2017 Nov 16. No abstract available.

21.

Fast quantitative parameter maps without fitting: Integration yields accurate mono-exponential signal decay rates.

Song R, Loeffler RB, Holtrop JL, McCarville MB, Hankins JS, Hillenbrand CM.

Magn Reson Med. 2018 Jun;79(6):2978-2985. doi: 10.1002/mrm.26964. Epub 2017 Oct 30. Erratum in: Magn Reson Med. 2019 Feb;81(2):1470.

22.

Automated vessel exclusion technique for quantitative assessment of hepatic iron overload by R2*-MRI.

Tipirneni-Sajja A, Song R, McCarville MB, Loeffler RB, Hankins JS, Hillenbrand CM.

J Magn Reson Imaging. 2018 Jun;47(6):1542-1551. doi: 10.1002/jmri.25880. Epub 2017 Oct 30.

23.

Removal of Arterial Vessel Contributions in Susceptibility-Weighted Images for Quantification of Normalized Visible Venous Volume in Children with Sickle Cell Disease

Winchell AM, Song R, Loeffler RB, Wang WC, Hankins JS, Helton KJ, Hillenbrand CM.

J Healthc Eng. 2017;2017. doi: 10.1155/2017/5369385.

24.

Pediatric to adult care co-location transitional model for youth with sickle cell disease.

Nolan VG, Anderson SM, Smeltzer MP, Porter JS, Carroll YM, Brooks IM, Elmagboul N, Gurney JG, Hankins JS.

Am J Hematol. 2018 Jan;93(1):E30-E32. doi: 10.1002/ajh.24953. Epub 2017 Nov 10. No abstract available.

25.

Removal of Arterial Vessel Contributions in Susceptibility-Weighted Images for Quantification of Normalized Visible Venous Volume in Children with Sickle Cell Disease.

Winchell AM, Song R, Loeffler RB, Wang WC, Hankins JS, Helton KJ, Hillenbrand CM.

J Healthc Eng. 2017;2017:5369385. doi: 10.1155/2017/5369385. Epub 2017 Aug 28.

26.

A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.

Estepp JH, Smeltzer MP, Kang G, Li C, Wang WC, Abrams C, Aygun B, Ware RE, Nottage K, Hankins JS.

Am J Hematol. 2017 Dec;92(12):1333-1339. doi: 10.1002/ajh.24906. Epub 2017 Sep 28.

27.

State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Puri L, Nottage KA, Hankins JS, Anghelescu DL.

Paediatr Drugs. 2018 Feb;20(1):29-42. doi: 10.1007/s40272-017-0263-z. Review.

PMID:
28853040
28.

Pediatric to Adult Care Transition: Perspectives of Young Adults With Sickle Cell Disease.

Porter JS, Wesley KM, Zhao MS, Rupff RJ, Hankins JS.

J Pediatr Psychol. 2017 Oct 1;42(9):1016-1027. doi: 10.1093/jpepsy/jsx088.

29.

Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease.

Penkert RR, Young NS, Surman SL, Sealy RE, Rosch J, Dormitzer PR, Settembre EC, Chandramouli S, Wong S, Hankins JS, Hurwitz JL.

Vaccine. 2017 Jun 22;35(29):3615-3620. doi: 10.1016/j.vaccine.2017.05.022. Epub 2017 May 26.

30.

Radial Ultrashort TE Imaging Removes the Need for Breath-Holding in Hepatic Iron Overload Quantification by R2* MRI.

Tipirneni-Sajja A, Krafft AJ, McCarville MB, Loeffler RB, Song R, Hankins JS, Hillenbrand CM.

AJR Am J Roentgenol. 2017 Jul;209(1):187-194. doi: 10.2214/AJR.16.17183. Epub 2017 May 15.

31.

The clinical severity of hemoglobin S/Black (A γδβ)0 -thalassemia.

Cancio MI, Aygun B, Chui DHK, Rothman JA, Scott JP, Estepp JH, Hankins JS.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26596. Epub 2017 Apr 28.

32.

Quantitative ultrashort echo time imaging for assessment of massive iron overload at 1.5 and 3 Tesla.

Krafft AJ, Loeffler RB, Song R, Tipirneni-Sajja A, McCarville MB, Robson MD, Hankins JS, Hillenbrand CM.

Magn Reson Med. 2017 Nov;78(5):1839-1851. doi: 10.1002/mrm.26592. Epub 2017 Jan 16.

33.

Hydroxyurea treatment effect on children with sickle cell disease and obstructive sleep apnea.

Grady AJ, Hankins JS, Haberman B, Schoumacher R, Stocks RM.

Sleep Breath. 2017 Sep;21(3):697-701. doi: 10.1007/s11325-017-1458-9. Epub 2017 Jan 11.

PMID:
28078488
34.

Can multi-slice or navigator-gated R2* MRI replace single-slice breath-hold acquisition for hepatic iron quantification?

Loeffler RB, McCarville MB, Wagstaff AW, Smeltzer MP, Krafft AJ, Song R, Hankins JS, Hillenbrand CM.

Pediatr Radiol. 2017 Jan;47(1):46-54. doi: 10.1007/s00247-016-3700-1. Epub 2016 Oct 17.

35.

Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia.

Nottage KA, Ware RE, Aygun B, Smeltzer M, Kang G, Moen J, Wang WC, Hankins JS, Helton KJ.

Br J Haematol. 2016 Oct;175(2):331-338. doi: 10.1111/bjh.14235. Epub 2016 Sep 8.

PMID:
27604981
36.

Barriers and facilitators to research participation among adults, and parents of children with sickle cell disease: A trans-regional survey.

Cronin RM, Hankins JS, Adams-Graves P, Thompson AA, Kalinyak K, Byrd J, McClain B, Kassim A, DeBaun M, Treadwell M.

Am J Hematol. 2016 Oct;91(10):E461-2. doi: 10.1002/ajh.24483. Epub 2016 Aug 4. No abstract available.

37.

Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.

Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL.

Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.

PMID:
27000103
38.

Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.

Hankins JS, Penkert RR, Lavoie P, Tang L, Sun Y, Hurwitz JL.

Exp Biol Med (Maywood). 2016 Apr;241(7):749-54. doi: 10.1177/1535370216636723. Epub 2016 Mar 2.

39.

Birth Prevalence of Sickle Cell Trait and Sickle Cell Disease in Shelby County, TN.

Smeltzer MP, Nolan VG, Yu X, Nottage KA, Davis BA, Yang Y, Wang WC, Gurney JG, Hankins JS.

Pediatr Blood Cancer. 2016 Jun;63(6):1054-9. doi: 10.1002/pbc.25936. Epub 2016 Feb 12.

PMID:
26871988
40.

Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial.

Hankins JS, McCarville MB, Rankine-Mullings A, Reid ME, Lobo CL, Moura PG, Ali S, Soares DP, Aldred K, Jay DW, Aygun B, Bennett J, Kang G, Goldsmith JC, Smeltzer MP, Boyett JM, Ware RE.

Am J Hematol. 2015 Dec;90(12):1099-105. doi: 10.1002/ajh.24198. Epub 2015 Nov 17.

41.

Distance from an Urban Sickle Cell Center and its Effects on Routine Healthcare Management and Rates of Hospitalization.

Smeltzer MP, Nolan VG, Yu X, Nottage KA, Wang WC, Hankins JS, Gurney JG.

Hemoglobin. 2016;40(1):10-5.

PMID:
26372097
42.

Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T.

Krafft AJ, Loeffler RB, Song R, Bian X, McCarville MB, Hankins JS, Hillenbrand CM.

Magn Reson Med. 2016 Aug;76(2):591-601. doi: 10.1002/mrm.25868. Epub 2015 Aug 26.

43.

Severe Autoimmune Hemolytic Anemia in an Infant Caused by Warm-reactive IGM and IGA Autoantibodies: A Case Report and Review of the Literature.

Branstetter CN, Hankins JS, Moreau D, Nottage KA.

J Pediatr Hematol Oncol. 2015 Aug;37(6):468-71. doi: 10.1097/MPH.0000000000000359. Review.

PMID:
26181418
44.

Paroxysmal cold hemoglobinuria due to an IgA Donath-Landsteiner antibody.

Whipple NS, Moreau DA, Moulds JM, Hankins JS, Wang WC, Nottage KA.

Pediatr Blood Cancer. 2015 Nov;62(11):2044-6. doi: 10.1002/pbc.25591. Epub 2015 Jun 5.

PMID:
26053459
45.

Prevalence of vitamin D deficiency in sickle cell disease: a systematic review.

Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG.

PLoS One. 2015 Mar 3;10(3):e0119908. doi: 10.1371/journal.pone.0119908. eCollection 2015. Review. Erratum in: PLoS One. 2015;10(5):e0128853.

46.

From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.

Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC.

Medicine (Baltimore). 2014 Dec;93(28):e215. doi: 10.1097/MD.0000000000000215.

47.

Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function.

Brown AO, Mann B, Gao G, Hankins JS, Humann J, Giardina J, Faverio P, Restrepo MI, Halade GV, Mortensen EM, Lindsey ML, Hanes M, Happel KI, Nelson S, Bagby GJ, Lorent JA, Cardinal P, Granados R, Esteban A, LeSaux CJ, Tuomanen EI, Orihuela CJ.

PLoS Pathog. 2014 Sep 18;10(9):e1004383. doi: 10.1371/journal.ppat.1004383. eCollection 2014 Sep.

48.

Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia.

Estepp JH, Winter B, Johnson M, Smeltzer MP, Howard SC, Hankins JS.

Pediatr Blood Cancer. 2014 Nov;61(11):2031-6. doi: 10.1002/pbc.25177. Epub 2014 Aug 17.

PMID:
25132074
49.

Genetic education and sickle cell disease: feasibility and efficacy of a program tailored to adolescents.

Porter JS, Matthews CS, Carroll YM, Anderson SM, Smeltzer MP, Hankins JS.

J Pediatr Hematol Oncol. 2014 Oct;36(7):572-7. doi: 10.1097/MPH.0000000000000226.

PMID:
25089602
50.

Assessment of sleep-related disorders in children with sickle cell disease.

Hankins JS, Verevkina NI, Smeltzer MP, Wu S, Aygun B, Clarke DF.

Hemoglobin. 2014;38(4):244-51. doi: 10.3109/03630269.2014.919941. Epub 2014 Jun 18.

PMID:
24941261

Supplemental Content

Loading ...
Support Center